NSE - Delayed Quote INR

CEIGALL INDIA LIMITED (CEIGALL.NS)

342.65

+0.55

+(0.16%)

At close: 3:30 PM GMT+5:30

Oil prices plunge 6% as Israel's retaliatory strike against Iran spares crude facilities

Oil plummeted as Israel's retaliation against Iran spared the country's oil infrastructure.

Yahoo Finance 35 minutes ago

CL=F

BZ=F
DJT stock skyrockets following Donald Trump's inflammatory MSG rally as election looms

Trump Media & Technology Group stock extended its five-week rally on Monday as investors bet on the former president winning the US election.

Yahoo Finance 2 hours ago

DJT

DJTWW
Nasdaq, stocks up ahead of Mag 7 earnings, oil prices drop

US stocks (^DJI, ^IXIC, ^GSPC) are moving on up at Monday's session open, as five of the Magnificent Seven tech names report earnings this week: Alphabet (GOOG, GOOGL), Amazon (AMZN), Apple (AAPL), Meta Platforms (META), and Microsoft (MSFT), The Morning Brief's Brad Smith and Yahoo Finance markets and data editor Jared Blikre check out market and sector gains following the opening bell, noting crude oil (CL=F, BZ=F) price reactions to Israel's escalating conflict with Iran. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 5 hours ago

BZ=F

XLE

^IXIC
NIO Stock Soars Over 12% Today: Massive Gains Fuel Hopes for an EV Comeback

NIO's Stock Surge Ignites Investor Optimism Amid Fresh Funding and Analyst Upgrades

GuruFocus.com 19 minutes ago

NIO
This Biotech Stock Has Doubled Its Value Today—Here's Why

Monte Rosa Therapeutics signed a development and commercialization deal with Novartis that could pay the biotech up to $2.1 billion.

Investopedia 57 minutes ago

GLUE

NVS
Monte Rosa Stock Doubles — Up 127% — On A Massive Deal With Novartis

Monte Rosa Therapeutics shares doubled Monday on a deal with Novartis to develop treatments for immune system conditions.

Investor's Business Daily 1 hour ago

GLUE

NVS

NVSEF
Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis

Evoke Pharma's Gimoti shows promise as a non-oral treatment for diabetic gastroparesis, driving shares up 90%

GuruFocus.com 1 hour ago

EVOK
Will Solid Total Payment Volume Aid PayPal's Q3 Earnings?

PYPL's third-quarter 2024 earnings are likely to reflect an improving Total Payment Volume along with an expanding clientele.

Zacks 1 hour ago

PYPL

FI

SHOP
Top Stock Movers Now: Carnival, Estee Lauder, Albemarle, and More

Major U.S. indexes gained at midday Monday as oil prices dropped and investors prepared for earnings from big tech companies.

Investopedia 2 hours ago

EL

CUK

^GSPC
These Stocks Are Moving the Most Today: Boeing, APA, Ford, Nvidia, Philips, ON Semi, McDonald’s, Procept BioRobotics, and More

Boeing launches sales of stock to help repair its ailing balance sheet, while APA Corp. tumbles as oil prices head lower. Ford is scheduled to report earnings on Monday, and Apple, Alphabet, Microsoft, Meta Platforms, and Amazon report quarterly earnings later this week.

Barrons.com 2 hours ago

PHG

NVDA

FANG
PHG vs. RMD: Which Stock Should Value Investors Buy Now?

PHG vs. RMD: Which Stock Is the Better Value Option?

Zacks 3 hours ago

PHG

RMD
Philips Shares Plunge 17% Amid Shocking China Sales Collapse -- What's Next for the Healthcare ...

Philips battles a steep 17% stock drop as China demand plummets, forcing the company to slash its sales outlook and rethink its growth strategy

GuruFocus.com 4 hours ago

PHG
Stocks to Watch Monday: Trump Media, Exxon Mobil, Chevron

↗️ Trump Media & Technology (DJT): Shares of the Trump-backed parent company rallied 15% in morning trading. (Check out our live election blog here). ↘️ Exxon Mobil (XOM), Chevron (CVX) and Occidental Petroleum (OXY): Shares of oil companies lost ground, as crude prices slid.

The Wall Street Journal 4 hours ago

ON

XOM

PHG
Trump Media Skyrockets 220% In A Month

With election odds swinging in Trump's favor, his media company's stock surges--will the rally hold, or is a crash looming?

GuruFocus.com 4 hours ago

DJT

DJTWW
Can Mixed Financials Have A Negative Impact on Arm Holdings plc's 's (NASDAQ:ARM) Current Price Momentum?

Arm Holdings' (NASDAQ:ARM) stock is up by 8.1% over the past three months. However, we decided to study the company's...

Simply Wall St. 5 hours ago

ARM
Philips Stock Plunges After China Warning. GE HealthCare Is Dropping Too.

It’s a reminder of how sluggish demand in the world’s second-largest economy could cause problems for the likes of Starbucks and Marriott.

Barrons.com 5 hours ago

PHG
Arm Holdings plc (NASDAQ:ARM) Enhances AI Capabilities with ExecuTorch, PyTorch Collaboration Brings Advanced Edge AI

We recently compiled a list of the 15 AI News Investors Should Not Miss. In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against the other AI stocks you should not miss. In a recent Tech Check program, CNBC’s Deirdre Bosa reports on how OpenAI’s head of Global […]

Insider Monkey 5 hours ago

ARM
Exploring Analyst Estimates for Teladoc (TDOC) Q3 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Teladoc (TDOC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.

Zacks 6 hours ago

TDOC
Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs

The agreement covers a class of drugs called "molecular glue degraders," which target abnormal protein functions associated with some diseases that are hard to treat with existing medications. Monte Rosa will also be eligible for future payments of up to $2.1 billion as well as royalties on net sales outside the U.S. Shares of Monte Rosa surged 32% to $6.46 in premarket trade following the news.

Reuters 6 hours ago

NVS

GLUE
Why Is Monte Rosa Therapeutics Stock Surging On Monday?

Monte Rosa Therapeutics Inc (NASDAQ:GLUE) stock is trading higher on Monday after the company announced a global exclusive development and commercialization license agreement with Novartis AG (NYSE:NVS) to advance VAV1 MGDs, including MRT-6160. MRT-6160 is currently in an ongoing Phase 1, single ascending dose (SAD)/multiple ascending dose (MAD) healthy volunteer study for immune-mediated conditions. Also Read: Monte Rosa Therapeutics’ AI And Machine Learning Platform Is Adding Significant Value

Benzinga 6 hours ago

GLUE

NVS

Performance Overview

Return	CEIGALL.NS	S&P BSE SENSEX
YTD	-18.22%	+1.42%
1-Year	-18.22%	+1.42%
3-Year	-18.22%	+1.42%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

CEIGALL INDIA LIMITED (CEIGALL.NS)

Related News

Oil prices plunge 6% as Israel's retaliatory strike against Iran spares crude facilities

DJT stock skyrockets following Donald Trump's inflammatory MSG rally as election looms

Nasdaq, stocks up ahead of Mag 7 earnings, oil prices drop

NIO Stock Soars Over 12% Today: Massive Gains Fuel Hopes for an EV Comeback

This Biotech Stock Has Doubled Its Value Today—Here's Why

Monte Rosa Stock Doubles — Up 127% — On A Massive Deal With Novartis

Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis

Will Solid Total Payment Volume Aid PayPal's Q3 Earnings?

Top Stock Movers Now: Carnival, Estee Lauder, Albemarle, and More

These Stocks Are Moving the Most Today: Boeing, APA, Ford, Nvidia, Philips, ON Semi, McDonald’s, Procept BioRobotics, and More

PHG vs. RMD: Which Stock Should Value Investors Buy Now?

Philips Shares Plunge 17% Amid Shocking China Sales Collapse -- What's Next for the Healthcare ...

Stocks to Watch Monday: Trump Media, Exxon Mobil, Chevron

Trump Media Skyrockets 220% In A Month

Can Mixed Financials Have A Negative Impact on Arm Holdings plc's 's (NASDAQ:ARM) Current Price Momentum?

Philips Stock Plunges After China Warning. GE HealthCare Is Dropping Too.

Arm Holdings plc (NASDAQ:ARM) Enhances AI Capabilities with ExecuTorch, PyTorch Collaboration Brings Advanced Edge AI

Exploring Analyst Estimates for Teladoc (TDOC) Q3 Earnings, Beyond Revenue and EPS

Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs

Why Is Monte Rosa Therapeutics Stock Surging On Monday?

Performance Overview